milrinone has been researched along with Inflammation in 11 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to evaluate the effect of preoperative inhalation of milrinone on cardiopulmonary bypass (CPB)-related inflammation." | 9.16 | Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. ( Gong, M; Lin, XZ; Lu, GT; Zheng, LJ, 2012) |
| " The authors evaluated the effects of milrinone on splanchnic oxygenation, systemic inflammation, and the subsequent acute-phase response in patients undergoing coronary artery bypass grafting." | 9.09 | Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). ( Asfour, B; Berendes, E; Loick, HM; Möllhoff, T; Rolf, N; Schmidt, C; Tjan, TD; Van Aken, H, 1999) |
| "To investigate the usefulness of low-dose milrinone on gastric intramucosal pH (pHi) and systemic inflammation in patients undergoing hypothermic cardiopulmonary bypass (CPB)." | 9.09 | Effect of low-dose milrinone on gastric intramucosal pH and systemic inflammation after hypothermic cardiopulmonary bypass. ( Akiyoshi, K; Irita, K; Okamoto, H; Takahashi, S; Taniyama, T; Yamaura, K, 2001) |
| " Whether biomarkers of myocardial necrosis, inflammation and apoptosis change in response to acute milrinone administration is not well established." | 7.75 | Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure. ( Bazari, R; Czerska, B; Gupta, RC; Hasan, R; Lanfear, DE; Sabbah, HN; Tita, C; Williams, C, 2009) |
| "The purpose of this study was to evaluate the effect of preoperative inhalation of milrinone on cardiopulmonary bypass (CPB)-related inflammation." | 5.16 | Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. ( Gong, M; Lin, XZ; Lu, GT; Zheng, LJ, 2012) |
| " The authors evaluated the effects of milrinone on splanchnic oxygenation, systemic inflammation, and the subsequent acute-phase response in patients undergoing coronary artery bypass grafting." | 5.09 | Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). ( Asfour, B; Berendes, E; Loick, HM; Möllhoff, T; Rolf, N; Schmidt, C; Tjan, TD; Van Aken, H, 1999) |
| "To investigate the usefulness of low-dose milrinone on gastric intramucosal pH (pHi) and systemic inflammation in patients undergoing hypothermic cardiopulmonary bypass (CPB)." | 5.09 | Effect of low-dose milrinone on gastric intramucosal pH and systemic inflammation after hypothermic cardiopulmonary bypass. ( Akiyoshi, K; Irita, K; Okamoto, H; Takahashi, S; Taniyama, T; Yamaura, K, 2001) |
| " Whether biomarkers of myocardial necrosis, inflammation and apoptosis change in response to acute milrinone administration is not well established." | 3.75 | Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure. ( Bazari, R; Czerska, B; Gupta, RC; Hasan, R; Lanfear, DE; Sabbah, HN; Tita, C; Williams, C, 2009) |
| " Milrinone, a phosphodiesterase (PDE)-3 inhibitor, is frequently used to treat perioperative pulmonary hypertension." | 3.73 | Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinone. ( Crisostomo, P; Kher, A; Meldrum, DR; Pitcher, JM; Tsai, BM; Wang, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Ručilová, V | 1 |
| Świerczek, A | 1 |
| Vanda, D | 1 |
| Funk, P | 1 |
| Lemrová, B | 1 |
| Gawalska, A | 1 |
| Bucki, A | 1 |
| Nowak, B | 1 |
| Zadrożna, M | 1 |
| Pociecha, K | 1 |
| Soural, M | 1 |
| Wyska, E | 1 |
| Pawłowski, M | 1 |
| Chłoń-Rzepa, G | 1 |
| Zajdel, P | 1 |
| Han, Y | 1 |
| Hou, R | 1 |
| Zhang, X | 1 |
| Liu, H | 1 |
| Gao, Y | 1 |
| Li, X | 1 |
| Qi, R | 1 |
| Cai, R | 1 |
| Qi, Y | 1 |
| Lanfear, DE | 1 |
| Hasan, R | 1 |
| Gupta, RC | 1 |
| Williams, C | 1 |
| Czerska, B | 1 |
| Tita, C | 1 |
| Bazari, R | 1 |
| Sabbah, HN | 1 |
| Gong, M | 1 |
| Lin, XZ | 1 |
| Lu, GT | 1 |
| Zheng, LJ | 1 |
| Chanani, NK | 1 |
| Cowan, DB | 1 |
| Takeuchi, K | 1 |
| Poutias, DN | 1 |
| Garcia, LM | 1 |
| del Nido, PJ | 1 |
| McGowan, FX | 1 |
| Takeno, M | 1 |
| Takagi, S | 1 |
| Sakuragi, S | 1 |
| Suzuki, S | 1 |
| Tsutsumi, Y | 1 |
| Nonogi, H | 1 |
| Goto, Y | 1 |
| Tsai, BM | 1 |
| Wang, M | 1 |
| Pitcher, JM | 1 |
| Kher, A | 1 |
| Crisostomo, P | 1 |
| Meldrum, DR | 1 |
| White, M | 1 |
| Ducharme, A | 1 |
| Ibrahim, R | 1 |
| Whittom, L | 1 |
| Lavoie, J | 1 |
| Guertin, MC | 1 |
| Racine, N | 1 |
| He, Y | 1 |
| Yao, G | 1 |
| Rouleau, JL | 1 |
| Schiffrin, EL | 1 |
| Touyz, RM | 1 |
| Möllhoff, T | 1 |
| Loick, HM | 1 |
| Van Aken, H | 1 |
| Schmidt, C | 1 |
| Rolf, N | 1 |
| Tjan, TD | 1 |
| Asfour, B | 1 |
| Berendes, E | 1 |
| Yamaura, K | 1 |
| Okamoto, H | 1 |
| Akiyoshi, K | 1 |
| Irita, K | 1 |
| Taniyama, T | 1 |
| Takahashi, S | 1 |
4 trials available for milrinone and Inflammation
| Article | Year |
|---|---|
Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass.
Topics: Administration, Inhalation; Analysis of Variance; Cardiopulmonary Bypass; Cytokines; Female; Hemodyn | 2012 |
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; C | 2006 |
Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB).
Topics: Acute-Phase Reaction; C-Reactive Protein; Cardiopulmonary Bypass; Double-Blind Method; Endotoxemia; | 1999 |
Effect of low-dose milrinone on gastric intramucosal pH and systemic inflammation after hypothermic cardiopulmonary bypass.
Topics: Body Temperature; Carbon Dioxide; Cardiopulmonary Bypass; Cytokines; Echocardiography, Transesophage | 2001 |
7 other studies available for milrinone and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Cyclic Nucleotide Phosphodiesterases, Type 7 | 2021 |
Amlexanox exerts anti-inflammatory actions by targeting phosphodiesterase 4B in lipopolysaccharide-activated macrophages.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, | 2020 |
Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure.
Topics: Adult; Aged; Apoptosis; Biomarkers; Cardiotonic Agents; Dose-Response Relationship, Drug; Fas Ligand | 2009 |
Differential effects of amrinone and milrinone upon myocardial inflammatory signaling.
Topics: Amrinone; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Cell Line; Cells, Cultured; Cycloox | 2002 |
Continuous milrinone infusion during preoperative anti-inflammatory therapy in inflammatory aortic aneurysm complicating severe congestive heart failure.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aortic Aneurysm, Thoracic; Aortic Valve Insuffici | 2002 |
Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinone.
Topics: Animals; Aorta; Aorta, Thoracic; Dose-Response Relationship, Drug; Drug Synergism; Hypertension, Pul | 2005 |